[1]Pancreas Study Group,Chinese Society of Gastroenterology,Chinese Medical Association,Editorial Board of Chinese Journal of Pancreatology,Editorial Board of Chinese Journal of Digestion.Chinese guidelines for the management of acute pancreatitis(Shanghai,2013)[J].J Clin Hepatol,2013,29(9):656-660.(in Chinese)中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编辑委员会,《中华消化杂志》编辑委员会.中国急性胰腺炎诊治指南(2013,上海)[J].临床肝胆病杂志,2013,29(9):656-660.
|
[2]INCE AT,BAYSAL B.Pathophysiology,classification and available guidelines of acute pancreatitis[J].Turk J Gastroenterol,2014,25(4):351-357.
|
[3]WAN B,FU H,YIN J,XU F.Efficacy of rhubarb combined with early enteral nutrition for the treatment of severe acute pancreatitis:a randomized controlled trial[J].Scand J Gastroenterol,2014,49(11):1375-1384.
|
[4]HUANG Q,LI M,YANG WW,et al.Analysis on the efficacy of low molecular weight heparin in treatment of severe acute pancreatitis[J].J Clin Exp Med,2013,12(18):1459-1461.(in Chinese)黄强,李宓,杨薇薇,等.低分子肝素治疗重症急性胰腺炎的疗效分析[J].临床和实验医学杂志,2013,12(18):1459-1461.
|
[5]LI XJ,CHEN YZ,XU LQ.Combined detection of serum amylase and lipase in the diagnosis of acute pancreatitis[J].Int J Lab Med,2011,32(21):2503-2504.(in Chinese)李锡敬,陈艳芝,许柳芹.血清淀粉酶和脂肪酶联合检测在急性胰腺炎诊断中的应用[J].国际检验医学杂志,2011,32(21):2503-2504.
|
[6]FENG GM,DU R.Combined dynamic detection of serum lipase and amylase in the diagnosis of acute pancreatitis[J].Med J Chin People's Health,2012,24(9):1038-1040.(in Chinese)丰光明,杜戎.联合动态检测血清脂肪酶和淀粉酶在急性胰腺炎诊断中作用[J].中国民康医学,2012,24(9):1038-1040.
|
[7]HOFMEYR S,MEYER C,WARREN BL.Serum lipase should be the laboratory test of choice for suspected acute pancreatitis[J].S Afr J Surg,2014,52(3):72-75.
|
[8]VOLZ KA,McG ILLICUDDY DC,HOROWITZ GL,et al.Eliminating amylase testing from the evaluation of pancreatitis in emergency department[J].West J Emerg Med,2010,11(4):344-347.
|
[9]KEDIA S,DHINGRA R,GARG PK.Recurrent acute pancreatitis:an approach to diagnosis and management[J].Trop Gastroenterol,2013,34(3):123-135.
|
[10]ZHAO H.ICAM-1 and acute pancreatitis[J].Surg Foreign Med Sci,2002,29(6):346-349.(in Chinese)赵华.ICAM-1与急性胰腺炎[J].国外医学:外科学分册,2002,29(6):346-349.
|
[11]KAPLAN M,YAZGAN Y,TANOGLU A,et al.Effectiveness of interleukin-1 receptor antagonist(Anakinra)on cerulein-induced experimental acute pancreatitis in rats[J].Scand J Gastroenterol,2014,49(9):1124-1130.
|
[12]WANG XY,TANG QQ,ZHANG JL,et al.Effect of SB203580 on pathologic change of pancreatic tissue and expression of TNF-αand IL-1βin rats with severe acute pancreatitis[J].Eur Rev Med Pharmacol Sci,2014,18(3):338-343.
|
[13]SHA T,YI JH.The diagnostic value of C-reaction protein in acute pancreatitis[J].Lab Med Clin,2013,10(8):962-964.(in Chinese)沙涛,易金宏.C-反应蛋白对急性胰腺炎的诊断价值[J].检验医学与临床,2013,10(8):962-964.
|
[14]CHEN SZ,LI YX,LI J,et al.Evaluation of serum C-reaction protein in acute pancreatitis[J].Mod Med Health,2013,29(18):2799-2801.(in Chinese)陈善正,李宜雄,李窖,等.血清C-反应蛋白在急性胰腺炎病情评估中的意义[J].现代医药卫生,2013,29(18):2799-2801.
|
[15]YIN G,HU G,CANG X,et al.C-reactive protein:rethinking its role in evaluating the severity of hyperlipidemic acute pancreatitis[J].Pancreas,2014,43(8):1323-1328.
|
[1] | Tong LIU, Shanzheng LI, Cheng ZHOU, Sutong LIU, Lihui ZHANG, Wenxia ZHAO. Study on the protective efect and mechanism of paeoniflorin on palmitic acid-induced HepG2 cells[J]. Journal of Clinical Hepatology, 2025, 41(3): 499-505. doi: 10.12449/JCH250316 |
[2] | Lai Xin, Zhou TaiCheng, Wei Jia. Association between HBV A1762T/G1764A double nucleotide substitution and liver diseases[J]. Journal of Clinical Hepatology, 2018, 34(9): 1990-1994. doi: 10.3969/j.issn.1001-5256.2018.09.034 |
[3] | Pang Ting, Xing HuiChun. Correlation between drug-resistance gene mutations and hepatocellular carcinoma in patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2017, 33(1): 82-86. doi: 10.3969/j.issn.1001-5256.2017.01.017 |
[4] | Du SenRong, Mao XiaoRong, Xiao Ping, Chen Hong. Effects of PARP-1 inhibitors AG-014699 and AZD2281 on proliferation and apoptosis of human hepatoma cell line HepG2[J]. Journal of Clinical Hepatology, 2015, 31(6): 943-946. doi: 10.3969/j.issn.1001-5256.2015.06.027 |
[5] | Wang LiPing, Han FangZheng, Li ChunYang, Yan Mei, Zhang YanChao, Yan XueBing. Evaluation of adefovir primary resistance and adefovir repulsive mutations of the HBV DNA P gene in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(8): 606-608. |
[6] | Jin WenWen, Xin YongNing, Dong QuanJiang, Zhao ShouFeng, Yu XinJuan, Jiang Man, Xu Jing, Xuan ShiYing. The preliminary study on the relationship between hepatitis B virus BCP gene mutations and HBV-related primary hepatocellular carcinoma in Qingdao[J]. Journal of Clinical Hepatology, 2012, 28(2): 130-134. |
[7] | Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430. |
[8] | Hong YuBo, Zhang Ting, Sun LiGuang. Association between IL-2 +114 (G/T) polymorphism and susceptibility to hepatitis B, cirrhosis, and hepatocellular carcinoma in Jilin province[J]. Journal of Clinical Hepatology, 2012, 28(12): 930-933. |
[9] | Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473. |
[10] | Zhang JianJun, Wu LiPing, Du RuiQing, Wang JianBin, Yao ZhanCheng, Yu GuiQin. Factors correlating with the liver inflammation grade ≥G2 in chronic HBV-infected patients with normal liver function[J]. Journal of Clinical Hepatology, 2012, 28(1): 35-38. |
[11] | Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290. |
[12] | Zou XiaoJing, Jiang XueQiang, Tian DeYing. Role of DC-SIGN on the maturation and activation of dendritic cells in chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 145-147+153. |
[13] | Xiong QiXiang, Xiong LiJuan. Hepatitis B virus infection and DNA methylation in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(8): 881-884. |
[14] | Pan Lei, Wei Xin, Xie YuMei, Hao ChunQiu, Wang JiuPing, Jia ZhanSheng, Bai XueFan. Anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV[J]. Journal of Clinical Hepatology, 2011, 27(1): 84-85+95. |
[15] | Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165. |
[16] | Xi HongLi, Liu FangFang, Yuan JiaYing, Yu YanYan. Significance and detection of IL-2、IL-4 and IFN-γ in PBMC from patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(6): 627-629. |
[17] | Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394. |
[18] | Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380. |
[19] | Xie DeSheng, Zhang QingBo, Chen ChangXing, Huang JianFang, Ma Jin, Huang HaiBin, Du Yao. The relationship between HBV gene mutation in HBV infected family and HLA class Ⅱ alleles[J]. Journal of Clinical Hepatology, 2010, 26(4): 383-386. |
[20] | Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159. |
1. | 中国抗癌协会肿瘤消融治疗专业委员会,中国临床肿瘤学会肿瘤消融治疗专家委员会,中国医师协会介入医师分会介入围手术学组. 复合式冷热消融治疗肝肿瘤围手术期管理专家共识. 中华内科杂志. 2025(02): 110-118 . ![]() | |
2. | 温钊,臧铁柱,宋晓改,张炫,江艳丽. 射频消融治疗包膜下与非包膜下早期肝细胞癌患者的远期预后. 河南医学研究. 2023(15): 2738-2744 . ![]() |